OKYO CEO Robert Dempsey Buys 15,000 Shares

What Happened
Robert John Dempsey (CEO) acquired 15,000 shares of OKYO Pharma Ltd in an open-market purchase on July 22, 2026 at $1.54 per share, for a total cost of $23,085. This Form 4/A is an amendment correcting the transaction code for that purchase; no other transactions were changed.

Key Details

• Transaction date: 2026-07-22; Price: $1.54 per share; Shares acquired: 15,000; Total value: $23,085.
• Transaction type/code: Open-market purchase (Code P). Amended filing corrects the transaction code only.
• Shares owned after the transaction: Not specified in the provided filing details.
• Filing status: This is an amended Form 4 (Form 4/A) to correct the transaction code; the filing itself does not indicate lateness.

Context
Open-market purchases by executives are often watched by investors as a potential positive signal, but the filing only reports the transaction and the code correction — it does not state motive. No derivative exercises, gifts, or tax-withholding events were reported in the provided amendment.